Market Tracker

09/29 4:45pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.1183
Delayed Data
As of Sep 29
 +0.0033 / +2.87%
Today’s Change
0.11
Today|||52-Week Range
0.53
-66.70%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.12
Today’s open0.12
Day’s range0.12 - 0.12
Volume1,658,395
Average volume (3 months)2,122,797
Market cap$14.7M
Dividend yield--
Data as of 4:02pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)-26.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.48

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...-0.08-3.86%
HTGMHTG Molecular Diagno...-0.08-3.31%
BASIBioanalytical System...+0.06+5.41%
FSIFlexible Solutions I...-0.02-0.91%
Data as of 3:59pm ET, 09/29/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts